Evidence map›Paper›PMID 37794054›Full record

ArticleNPJ digital medicine2023

Autonomous artificial intelligence increases real-world specialist clinic productivity in a cluster-randomized trial.

Michael D Abramoff, Noelle Whitestone, Jennifer L Patnaik, Emily Rich, Munir Ahmed, Lutful Husain, Mohammad Yeadul Hassan, Md Sajidul Huq Tanjil, Dena Weitzman, Tinglong Dai and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in NPJ digital medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05182580 (Assessing the Impact of Using Autonomous Artificial Intelligence), which is not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05182580 nacompletednot on this map

Assessing the Impact of Using Autonomous Artificial Intelligence (AI) for Pre-screening of Diabetic Retinopathy (DR) and Diabetic Macular Edema on Physician Productivity in Bangladesh

TypeinterventionalSponsorOrbisRan2022 to 2022Enrolled993ConditionsDiabetic Retinopathy, Diabetic Macular EdemaArmsResults utilized from autonomous AI diagnostic system for diabetic retinopathy and/or diabetic macular edema
3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Artificial intelligence in diabetic retinopathy: from automated screening to risk-stratified care.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. A Review of Recent Developments in Artificial Intelligence and Big Data Technologies for Ophthalmology Referrals and Clinical Practice.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  11. Review
  12. Article
  13. Artificial intelligence in ophthalmology clinical trials: a narrative review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Michael D AbramoffUniversity of Iowa, Iowa City, Iowa, USA. michael-abramoff@uiowa.edu.ORCID http://orcid.org/0000-0002-3490-0037
Noelle WhitestoneOrbis International, New York, New York, USA.ORCID http://orcid.org/0000-0003-3355-3878
Jennifer L PatnaikOrbis International, New York, New York, USA.
Emily RichOrbis International, New York, New York, USA.
Munir AhmedOrbis Bangladesh, Dhaka, Bangladesh.
Lutful HusainOrbis Bangladesh, Dhaka, Bangladesh.
Mohammad Yeadul HassanOrbis Bangladesh, Dhaka, Bangladesh.
Md Sajidul Huq TanjilDeep Eye Care Foundation, Rangpur, Bangladesh.
Dena WeitzmanDigital Diagnostics Inc, Coralville, Iowa, USA.
Tinglong DaiCarey Business School, Johns Hopkins University, Baltimore, Maryland, USA.ORCID http://orcid.org/0000-0001-9248-5153
Brandie D WagnerDepartment of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USA.
David H CherwekOrbis International, New York, New York, USA.
Nathan CongdonOrbis International, New York, New York, USA.
Khairul IslamDeep Eye Care Foundation, Rangpur, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autonomous artificial intelligence (AI) promises to increase healthcare productivity, but real-world evidence is lacking. We developed a clinic productivity model to generate testable hypotheses and study design for a preregistered cluster-randomized clinical trial, in which we tested the hypothesis that a previously validated US FDA-authorized AI for diabetic eye exams increases clinic productivity (number of completed care encounters per hour per specialist physician) among patients with diabetes. Here we report that 105 clinic days are cluster randomized to either intervention (using AI diagnosis; 51 days; 494 patients) or control (not using AI diagnosis; 54 days; 499 patients). The prespecified primary endpoint is met: AI leads to 40% higher productivity (1.59 encounters/hour, 95% confidence interval [CI]: 1.37-1.80) than control (1.14 encounters/hour, 95% CI: 1.02-1.25), p < 0.00; the secondary endpoint (productivity in all patients) is also met. Autonomous AI increases healthcare system productivity, which could potentially increase access and reduce health disparities. ClinicalTrials.gov NCT05182580.

Identifiers

PMID37794054
PMCPMC10550906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.